Sera Prognostics

Women's health company dedicated to improving maternal and neonatal health by providing innovative pregnancy biomarker tests. Publicly traded on NASDAQ (SERA). Developed PreTRM test for predicting preterm birth risk.

Location
Salt Lake City, Utah, USA
Founded
2008
Investors
1
Categories
womens-health, diagnostics, pregnancy, biomarkers, public-company

Investors

NameLocationTypeStagesPortfolio
aMoonTel Aviv, Israelbiotech-focused
series-aseries-b+2
8